Related Experiment Video
Updated: Aug 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple
Cornelia Buerger1, Nele Plock, Pejman Dehghanyar
1Department of Clinical Pharmacy, Institute of Pharmacy, Freie Universitaet Berlin, D-12169 Berlin, Germany.
Abstract:
The antimicrobial agent linezolid is approved for the treatment of severe infections caused by, e.g., methicillin-resistant Staphylococcus strains. In order to evaluate the penetration of linezolid into the interstitial space fluid (ISF) of subcutaneous adipose tissue and skeletal muscle of the target population, a microdialysis study was performed with 12 patients with sepsis or septic shock after multiple intravenous infusions. Unbound linezolid concentrations were determined for plasma and microdialysates by use of a validated high-performance liquid chromatography method. Individual compartmental pharmacokinetic (PK) analysis was performed using WinNonlin. In vivo microdialysis was found to be feasible for the determination of unbound linezolid concentrations at steady state in the ISF of critically ill patients. On average, linezolid showed good distribution into ISF but with high interindividual variability. A two-compartment model was fitted to unbound concentrations in plasma with a geometric mean distribution volume of 62.9 liters and a mean clearance of 9.18 liters/h at steady state. However, disposition characteristics changed intraindividually within the time course. In addition, an integrated model for simultaneous prediction of concentrations in all matrices was developed and revealed similar results. Based on the model-predicted unbound concentrations in ISF, a scheme of more-frequent daily dosing of linezolid for some critically ill patients might be taken into consideration to avoid subinhibitory unbound concentrations in the infected tissue. The developed integrated model will be a valuable basis for further PK data analysis to explore refined dosing guidelines that achieve effective antimicrobial therapy in all patients by use of the population PK approach.
Insights
Linezolid effectively distributes into interstitial fluid in critically ill patients, but high variability suggests personalized dosing may be needed for optimal treatment of severe infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Critical Care Medicine
Background:
- Linezolid is crucial for treating severe infections, including those caused by methicillin-resistant Staphylococcus strains.
- Understanding linezolid's penetration into tissue interstitial fluid is vital for optimizing therapy in critically ill patients.
Purpose of the Study:
- To evaluate linezolid penetration into subcutaneous adipose tissue and skeletal muscle interstitial space fluid (ISF) in patients with sepsis or septic shock.
- To determine unbound linezolid concentrations in plasma and ISF using microdialysis and pharmacokinetic analysis.
Main Methods:
- A microdialysis study was conducted with 12 critically ill patients receiving multiple intravenous linezolid infusions.
- Unbound linezolid concentrations were measured in plasma and ISF via high-performance liquid chromatography.
- Individual and integrated pharmacokinetic (PK) modeling was performed using WinNonlin.
Main Results:
- In vivo microdialysis successfully determined steady-state unbound linezolid concentrations in ISF.
- Linezolid demonstrated good ISF distribution, but with significant interindividual variability.
- A two-compartment model showed a mean distribution volume of 62.9 L and clearance of 9.18 L/h, with intraindividual changes over time.
Conclusions:
- Current linezolid dosing may require adjustments for some critically ill patients to maintain effective concentrations in infected tissues.
- An integrated PK model provides a foundation for developing refined dosing guidelines using a population PK approach.
- Personalized dosing strategies are essential to ensure effective antimicrobial therapy and avoid subinhibitory concentrations in diverse patient populations.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacokinetics in Pediatric Patients: Drug Excretion
Measurement of Bioavailability: Pharmacokinetic Methods
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Distribution: Plasma Protein Binding